The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Immunomodulatory and anti‐inflammatory effects of chondroitin sulphate
Open accessAbstract
Biochemistry of chondrotin sulphate Mechanism of action of chondroitin sulphate Human use of chondroitin sulphate Conclusions Chondroitin sulphate (CS) is a natural glycosaminoglycan present in the extracellular matrix and is formed by the 1–3 linkage of D‐glucuronic acid to N‐acetylgalactosamine. In chondrocytes, CS diminishes interleukin‐1 p(IL‐1p)‐induced increases in p38 mitogen‐activated protein kinase (p38MAPK) and signal‐regulated kinase 1/2 (Erk1/2) phosphorylation, and decreases nuclear factor‐KB (NF‐kB) nuclear translocation and as a consequence, reduces the formation of pro‐inflammatory cytokines, IL‐1 p and TNF‐a, and pro‐inflammatory enzymes, such as phospholipase A2 (PLA2), cyclooxygenase 2 (COX‐2) and nitric oxide synthase‐2 (NOS‐2). The mechanism of action of CS explains its beneficial effect on the cartilage, synovial membrane and subchondral bone. On the other hand,in vivo, CS given orally prevents hepatic NF‐kB nuclear translocation, suggesting that systemic CS may elicit an anti‐inflammatory effect in many tissues besides the articulation. There is preliminary evidence showing that in human beings, CS may be of benefit in other diseases where inflammation is an essential marker, such as psoriasis and atherosclerosis. The review of the literature suggest that CS might also be of interest for the treatment of other diseases with an inflammatory and/or autoimmune character, such as inflammatory bowel disease, degenerative diseases of the central nervous system and stroke, multiple sclerosis and other autoimmune diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850 · cited 1×
“Moreover, markers of inflammation are highly predictive of cardiovascular events [80].”
BackgroundActivators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F. M., Moye, L. A., Goldman, S., Flaker, G. C., & Braunwald, E. (1998) · Circulation · doi:10.1161/01.cir.98.9.839 · Cited by 1,389 · cited 1×
“The Cholesterol and Recurrent Events (CARE) trial demonstrated that the presence of inflammation after a myocardial infarction is associated with increased risk of recurrent coronary events [78].”
BackgroundGlucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis
Clegg, D. O., Reda, D. J., Harris, C. L., Klein, M. A., O'Dell, J. R., Hooper, M. M., Bradley, J. D., Bingham, C. O., Weisman, M. H., Jackson, C. G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052771 · Cited by 1,329
Risner, M. E., Saunders, A. M., Altman, J. F. B., Ormandy, G. C., Craft, S., Foley, I. M., Zvartau-Hind, M. E., Hosford, D. A., Roses, A. D., & for the Rosiglitazone in Alzheimer's Disease Study Group (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500369 · Cited by 686
The bright side of the glial scar in CNS repair
Rolls, A., Shechter, R., & Schwartz, M. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2591 · Cited by 674
NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo
Eriksen, J. L., Sagi, S. A., Smith, T. E., Weggen, S., Das, P., McLendon, D. C., Ozols, V. V., Jessing, K. W., Zavitz, K. H., Koo, E. H., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18162 · Cited by 634
Cañas, N., Valero, T., Villarroya, M., Montell, E., Vergés, J., García, A. G., & López, M. G. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.123505 · Cited by 92 · cited 1×
“In human neuroblastoma SH-SY5Y cells subjected to oxidative stress, CS reduces the formation of reactive oxygen species (ROS) induced by both H2O2 (extracellular ROS) and Rot/oligo (intracellular ROS), effects associated with an increased AKT/PI3K phosphorylation and heme oxygenase-1 expression [127].”
BackgroundSelf-citation
Cited by
Biomedical applications of biodegradable polymers
Ulery, B. D., Nair, L. S., & Laurencin, C. T. (2011) · Journal of Polymer Science Part B: Polymer Physics · doi:10.1002/polb.22259 · Cited by 2,206
Franz, S., Rammelt, S., Scharnweber, D., & Simon, J. C. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.078 · Cited by 1,391
Metadata
- Authors
- du Souich, P., García, A. G., Vergés, J., & Montell, E.
- Venue
- Journal of Cellular and Molecular Medicine
- Publisher
- Wiley
- Published
- 2009-08
- Volume
- 13
- Issue
- 8a
- Pages
- 1451-1463
- ISSN
- 1582-1838 (ISSN-L)
- 1582-4934
- OpenAlex
- W2004416339
- Cited by
- 195
- References
- 8
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Immunomodulatory and anti‐inflammatory effects of chondroitin sulphate. https://app.cochat.ai/papers/10.1111/j.1582-4934.2009.00826.x
- The paper
- du Souich, P., García, A. G., Vergés, J., & Montell, E. (2009). Immunomodulatory and anti‐inflammatory effects of chondroitin sulphate. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/j.1582-4934.2009.00826.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.